GSK , Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...
There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...
Sanofi (SNY), and CSL (CSLLY) win $72M U.S. contract to expand bird flu vaccine production amid fears of human transmission.
Federal officials plan to double the stockpile of emergency bird flu vaccines as they identify more people infected with the ...
One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...
The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...
As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its ...
According to Research by , Vaccine Market Growth is Driven by Increasing Government Support, Technological Innovations, and Growing Demand for Immunization, with Key Contributions from mRNA and ...
GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, ...
GSK Plc, Sanofi, and CSL Ltd. secured $72 million from the US government to ramp up production of bird flu vaccines as a nationwide outbreak among livestock and poultry has led to several human ...